Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6

CRS and ICANS incidence and severity were consistent with the pivotal EPCORE NHL-1 trial findings. The results support feasibility of outpatient administration and monitoring of epcoritamab in 2L+ DLBCL without mandatory hospitalization for monitoring.

Authors

Institutions

Publication Details

Journal
Clinical Lymphoma Myeloma & Leukemia
Published
2026-02-01
DOI
https://doi.org/10.1016/j.clml.2026.02.006
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6

Mark Fesler, Suchitra Sundaram Sundaram, Sami Ibrahimi, Fernando Vargas Madueno et al.
Clinical Lymphoma Myeloma & Leukemia
CAR-T cell therapy research
article

Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6

Mark Fesler, Suchitra Sundaram Sundaram, Sami Ibrahimi, Fernando Vargas Madueno, Kristin Conte, Christian Winther Eskelund, Kojo Osei-Bonsu, Alexander P. Boardman, John Hrom, Ralph V. Boccia, Seema Naik, Thomas Doerr, Jeff P. Sharman, Eric H. Lee, Mitul Gandhi, Rakhee Vaidya, J. Erika Haydu, Christina Y. Lee, David Andorsky, Neha Dixit, Yang Bai, Adelba Torres Lopez, Bradley Lash
article en

Abstract

CRS and ICANS incidence and severity were consistent with the pivotal EPCORE NHL-1 trial findings. The results support feasibility of outpatient administration and monitoring of epcoritamab in 2L+ DLBCL without mandatory hospitalization for monitoring.

Clinical Lymphoma Myeloma & Leukemia
Atrium Health Wake Forest Baptist (US), Lehigh Valley Hospital-Pocono (US), Memorial Sloan Kettering Cancer Center (US), AbbVie (United States) (US), St. Luke's Hospital (US), Memorial Healthcare System (US), Hattiesburg Clinic (US), Stony Brook Medicine (US), Auxilio Mutuo Hospital (PR), Virginia Cancer Specialists (US), Center for Cancers and Blood Disorders (US), Rocky Mountain Cancer Centers (US), Compassionate Cancer Care (US), Willamette Valley Cancer Institute and Research Center (US), Forrest General Hospital (US), Center for Cancer Research (US), Genmab (Denmark) (DK), University of Oklahoma Health Sciences Center (US), Stony Brook University (US), Penn State Milton S. Hershey Medical Center (US), Icahn School of Medicine at Mount Sinai (US)
Eli Lilly and Company, Pfizer, AstraZeneca, Pharmacyclics
Good health and well-being
Openalex Percentile: Top 47%
CAR-T cell therapy research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.